Skip to content

Mechanism of upper limb spasmodic brain plasticity after cerebral infarction treated by electroacupuncture combined with low frequency rTMS

Mechanism of upper limb spasmodic brain plasticity after cerebral infarction treated by electroacupuncture combined with low frequency rTMS

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032090
Enrollment
Unknown
Registered
2020-04-19
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper limb spasm after cerebral infarction

Interventions

Sponsors

Shenzhen Bao'an Traditional Chinese Medicine Hospital Group
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) meet the above diagnostic criteria; (2) first onset, with a course of 1-6 months, aged 35-65 years; (3) the upper buckling model spastic paralysis, out the hierarchical II ~IV period;Improved Ashworth was used to evaluate the degree of muscle tension of hemiplegic limbs: 1 <= MAS <= 3; (4) modified Rankin scale 1 <= MRS <= 3; (5) the patient has clear consciousness, stable vital signs, stable condition, and can cooperate with treatment and efficacy observer; (6) the patient and his/her family agreed to participate in the case registration study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) persons with conscious disorders and severe aphasia; (2) persons with secondary epilepsy, family history of epilepsy or previous abnormal mental state; (3) patients with previous disease history of other nervous system and motor system, which affected the limb movement function of the affected side; (4) patients with a history of brain trauma or severe heart disease (such as atrial fibrillation, valvular heart disease, etc.); (5) patients with metal implants (such as pacemaker, coronary stent, etc.); (6) patients who take drugs with skeletal muscle relaxation effect at the same time; (7) patients in pregnancy or lactation period.

Design outcomes

Primary

MeasureTime frame
Modified Ashworth table;PAS25, PAS10;Fugl-mever rating scale;

Secondary

MeasureTime frame
Modified Barthel index scale;MEPs;rMT;

Countries

China

Contacts

Public ContactZhang Yu

Shenzhen Bao'an Traditional Chinese Medicine Hospital Group

185180985@qq.com+86 18098993370

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026